Atypical antipsychotic agents in the treatment of Schizophrenia and other psychiatric disorders. Part II: Special considerations
- PMID: 9671350
- DOI: 10.4088/jcp.v59n0610
Atypical antipsychotic agents in the treatment of Schizophrenia and other psychiatric disorders. Part II: Special considerations
Comment in
-
Inaccurate information on quetiapine.J Clin Psychiatry. 1998 Dec;59(12):687. doi: 10.4088/jcp.v59n1208a. J Clin Psychiatry. 1998. PMID: 9921704 No abstract available.
Similar articles
-
Mental health care from the public perspective: the Texas Medication Algorithm Project.J Clin Psychiatry. 1999;60 Suppl 3:16-20; discussion 21. J Clin Psychiatry. 1999. PMID: 10073372
-
New vs. old antipsychotics: the Texas experience.J Clin Psychiatry. 1999;60 Suppl 1:23-5; discussion 28-30. J Clin Psychiatry. 1999. PMID: 10037167
-
Clozapine and hospitalization.Psychiatr Serv. 1999 Jan;50(1):114-6. doi: 10.1176/ps.50.1.114b. Psychiatr Serv. 1999. PMID: 9890595 No abstract available.
-
Cost-effectiveness of atypical antipsychotics in chronic schizophrenia.Hosp Med. 1999 Jun;60(6):410-3. doi: 10.12968/hosp.1999.60.6.1132. Hosp Med. 1999. PMID: 10492711 Review.
-
New antipsychotic agents: emerging clinical profiles.J Clin Psychiatry. 1999;60 Suppl 1:12-7; discussion 28-30. J Clin Psychiatry. 1999. PMID: 10037165 Review.
Cited by
-
Psychotic symptoms in patients with medical disorders.Curr Psychiatry Rep. 2004 Jun;6(3):216-24. doi: 10.1007/s11920-004-0067-z. Curr Psychiatry Rep. 2004. PMID: 15142475 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical